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1. Introduction 
In recent years Nanotechnology form a fascinating interdisciplinary area that brings 
together biology, material science, and nanoelectronics. Moreover, mainly three different 
applications of nanotechnology particularly suited to biomedicine: diagnostic techniques, 
drugs, and prostheses and implants. Interest is booming in biomedical applications for use 
outside the body, such as diagnostic sensors and “labon- a-chip” techniques, which are 
suitable for analyzing blood and other samples, and for inclusion in analytical instruments 
for R&D on new drugs. For inside the body, many companies are developing 
nanotechnology applications for anticancer drugs, implanted insulin pumps, and gene 
therapy. Nanotechnology also has applications in the tissue engineering field, helping 
people who are in need of new bones, teeth, or other body tissues by replacing damaged or 
missing tissue with an equivalent material. The biological material is introduced into a 
mould to produce a body part with a characteristic shape, a bone for example. There is a 
long list of these devices such as orthopedic joint prostheses cardio vascular aids and dental 
implants; however the theme prepared aims only the first one; orthopedic joint prostheses, 
with particular emphasis on hip and knee ortheoplasty. Survival of the arthroplasty 
depends among others on the age of the patient. In patients over 65, failure rate after ten 
years is about 7 %. In younger patients (<60 year) failure rates are significantly higher 
(>15%). As the number of arthroplasties will grow due to the ageing of our population, a 
considerable percentage of this increase will consist of revision arthroplasties. Because 
results of revisions are worse than those of primary arthoplasties, improved procedures for 
placement of joint prostheses have to be found. Therefore, an implant made of a 
mechanically strong material that can support and even enhance the integration of 
orthopedic implants will increase the clinical effectiveness of bone implants and will make it 
less likely that the implants will wear out and need to be replaced. The worldwide 
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emergence of nano scale science and engineering will make viable the production of 
enhanced biomaterials with high compatibility of interacting with the human biological 
systems.  
Of significant biological importance when utilizing this technology is to exercise control 
over mechanical properties at the material-biological interface (Discher et al., 2005). 
Manipulation of mechanical properties within these systems can dictate cell response and 
affect many physiological responses (LeDuc and Robinson, 2007; LeDuc and Bellin, 2006). 
CNTs have already been employed in the mechanics of materials domain for decades 
because of their high strength, which makes them ideal for a variety of applications 
including polymeric composite systems. Their successes in vivo though have been 
inhibited by physiological challenges as the promise of introducing pristine 
nonfunctionalized CNTs in polymer matrixes has been limited because this type of 
nanomaterial is practically insoluble and can accumulate in cells, organs, and tissues with 
dangerous effects (Zanello et al., 2006; Lam et al., 2004). This problem has been overcome, 
however, by chemically modifying the surfaces of the CNTs, which addresses the 
solubility challenges in most solvents and polymers (Colvin, 2003; Ajayan and Tour, 2007; 
Coleman et al., 2006).   
However, current joint implants last only 10 to 15 years before failing. Because of this, many 
patients have to go through a revision surgery due to the failure of bone implants. The main 
reason for implant failure is aseptic loosening of the implant from juxtaposed bone. In this 
light, polymethyl methacrylate (PMMA) has been used widely in orthopedics to improve 
the bonding between the implant and bone. In total hip replacement procedures, PMMA 
cement is located at the bone-implant interface and plays an important role in inhibiting the 
aseptic loosening processes. PMMA cement is associated with several drawbacks that limit 
its efficacy (such as strong exothermic reactions, weak radiopacity and poor fatigue 
strength; all leading to insufficient bonding to bone). With an expectation of increased 
revision surgeries and patients receiving orthopaedic implants in the coming years, the 
emphasis of joint replacement research needs to be focused on improving the mechanical 
and biocompatibility properties of bone cements. As nanotechnology has been extensively 
used to improve mechanical and surface properties of implant materials, it certainly 
provides a unique opportunity to modify the material properties of currently used bone 
cements in a more precise manner.  
For developing a biologically inspired composite system, there are numerous available 
composite materials. One particular area that has shown promise is in using bone cements 
such as PMMA. PMMA has been extensively used in orthopaedic surgery as a biomaterial 
that fixes artificial joints to bone and fills bone defects, as well as a drug-delivery system 
(Rimessi et al., 2009). One well documented issue with bone cements is that the fixation 
strength of PMMA cement to bone is primarily dependent on mechanical characteristics. To 
address this, a complementary material, hydroxyapatite (HA) (Singh et al., 2008), has been 
used with PMMA. HA is a prime constituent of bone cements and is particularly useful for a 
diversity of reasons including its ability to bond chemically with living bone tissues as well 
as its chemical and crystalline similarity to human skeletal apatite. These systems alone 
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though exhibit intrinsic brittleness and poor strength, thus restricting its clinical applications 
under load-bearing conditions (Curtin and Sheldon, 2004; Vallo et al., 2004; McGee et al., 
2000; Stevens, 2008). 
In the present chapter we will review the previous bone cements, future prospects and 
application of carbon nanotubes based nanocomposites for the development of next 
generation active bone cement for biomedical applications, which have been particularly 
relevant in our research group at TEMA. 
2. Polymethylmethacrylate (PMMA) or bone cement 
Polymethylmethacrylate (PMMA), a clear plastic, is a pretty versatile material. Plexiglas 
windows are made from PMMA. Acrylic paints contain PMMA. It also remains one of the 
most enduring materials in orthopedic surgery where it has a central role in the success of 
total joint replacement. Being part of a group of medical materials called 'bone cement', its 
use includes the fixation of biomaterials such as artificial joints to bone, the filling of bone 
defects and, also, as a drug-delivery system. Beginning in the 1970s, many successful 
results have been reported for total hip replacement using PMMA cement; however, 
failures of fixation have also occurred. The fixation strength of PMMA cement to bone is 
mainly dependent on mechanical interlocking, but it is known that a fibrous tissue layer 
intervenes between cement and bone - PMMA cement never bonds directly to the bone. 
One of the problems associated with the conventional types of bone cement used is their 
unsatisfactory mechanical and exothermic reaction properties. Other problems with 
PMMA cement include the biological response, leakage of the monomer of 
methylmethacrylate and a high curing temperature, which can damage cell activity. 
Ideally, a bone cement material must functionally match the mechanical behavior of the 
tissue to be replaced, it must be able to form a stable interface with the surrounding 
natural tissue and be effective in guided tissue regenerative procedures, it should be easy 
to handle, biologically compatible, non-supporting of microbial growth, and non-
allergenic. 
3. Hydroxyapatite (HA) 
Hydroxyapatite (HA) is another key constituent of bone cements because of its ability to 
bond chemically with living bone tissues; this is due to its similar chemical composition and 
crystal structure to apatite in the human skeletal system. However, the intrinsic brittleness 
and poor strength of sintered HA restricts its clinical applications under load-bearing 
conditions. 
4. Carbon nanotubes  
Carbon nanotubes (CNTs) are allotropes of carbon with a cylindrical nanostructure. 
Nanotubes have been constructed with length-to-diameter ratio of up to 132,000,000:1 (Dai, 
2002) significantly larger than for any other material. These cylindrical carbon molecules 
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have unusual properties, which are valuable for nanotechnology, electronics, optics and 
other fields of materials science and technology. 
Carbon nanotubes are the strongest and stiffest materials yet discovered in terms of tensile 
strength and elastic modulus respectively. This strength results from the covalent sp2 
bonds formed between the individual carbon atoms. In 2000, a multi-walled carbon 
nanotube was tested to have a tensile strength of 63 giga pascals (Gpa) (Yu et al., 2000). 
Further studies, conducted in 2008, revealed that individual CNT shells have strengths of 
up to ~100 GPa, which is in good agreement with quantum/atomistic models (Peng et al., 
2008). Since carbon nanotubes have a low density for a solid of 1.3 to 1.4 g/cm3 (Collins, 
2000) its specific strength of up to 48,000 kN-m/kg is the best of known materials, 
compared to high-carbon steel's 154 kN-m/kg. Standard single-walled carbon nanotubes 
can withstand a pressure up to 24 GPa without deformation. They then undergo a 
transformation to super hard phase nanotubes. Maximum pressures measured using 
current experimental techniques are around 55GPa. The bulk modulus of superhard phase 
nanotubes is 462 to 546 GPa, even higher than that of diamond (420) GPa for single 
diamond crystal) (Popov, 2003).  
4.1. Dispersion of functionalized carbon nanotubes in the water 
Commercially available (purity >95%, Nanocyl-3150) multi-walled carbon nanotubes with 
lengths of 1-5 µm and diameters of 5-10 nm were suspended in 3:1 mixture of concentrated 
H2SO4 (18.4 M)/HNO3(16M) and sonicated in a water bath for 24 hours. The resulting 
suspension was then diluted with water, and the MWCNTs were collected on a 100-nm-pore 
membrane filter and washed with deionized water. The resultant functionalized MWCNTs 
(MWCNTs-COOH) were investigated by FTIR (Nicolet AVATAR-360 FT-IR 
spectrophotometer) and visible micro-Raman spectra (Jobyin Ivon T64000, =514.5 nm). IR 
spectra of COOH functionalized MWCNTs shows carbonyl stretching at 1729 cm-1 but in 
Raman spectra this signal is inactive. In Raman spectra a band centred at 1300 cm-1 is 
attributed to sp3-hybridized carbon in the hexagonal framework of the nanotube walls. This 
disorder mode band is enhanced, as functional groups are attached to the side walls of the 
nanotubes (Ying et al., 2003; Dyke and Tour, 2003; Georgakilas et al., 2002; Dyke and Tour, 
204; Wang and Tseng, 2007). Acid-base titrations (Zho and Stoddart, 2009; Tsang et al., 
1994) were performed to determine the concentration of COOH groups for acid-treated 
MWCNTs. The result indicates that around 3% Carbon atoms are functionalized with 
COOH groups. 
To obtain a homogeneous dispersion of MWCNTs-COOH in water, it was used an aqueous 
dispersant “NanoSperse AQ” (http://www.nano-lab.com/dispersant-suspensions.html) a 
surfactant, which consists mainly of poly (oxy-1,2-ethanediyl), tertramethyl-5-decyne-4,7-
diol and butoxyethanol, respectively. The typical procedure involves mixing of 100 mg of 
MWCNTs-COOH in 100 ml of distilled water with 4 ml of dispersant, and then keeping the 
mixture in a ultrasonication bath for one hour. The final product presents a black colour 
with no settling of MWCNTs (Figure 1). 
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Figure 1. Schematic diagram for chemical fictionalization of MWCNTs and their dispersion in water 
5. Carbon nanotube-reinforced poly (methyl methacrylate) 
nanocomposite for bone cement application 
Carbon nanotubes, due to their small dimensions and high aspect ratio, exhibit exceptional 
physical and chemical properties (Iijima, 1991; Baughman et al., 2002; Usui et al., 2008). No 
other material can compete with their outstanding combination of mechanical, thermal and 
electronic properties, which makes them an outstanding reinforcement material for 
composites (Goller et al., 2003; Cholpek et al., 2006; Price et al., 2003; Peigney, 2003). The 
ideal reinforcement material would impart mechanical integrity to the composite at high 
loadings, without diminishing its bioactivity.  Hydroxyapatite (HA) is the prime constituent 
of bone cements, because of its ability to bond chemically with living bone tissues due to its 
similar chemical composition and crystal structure to apatite in the human skeletal system. 
However, the intrinsic brittleness and poor strength of sintered HA restricts its clinical 
applications under load-bearing conditions (Dimitrievska et al., 2008; White and Best, 2007). 
The polymethyl methacrylate is another material commonly used as bone cement; however, 
its low mechanical strength makes the use of PMMA problematic. In the present work, a 
novel nanocomposite material was synthesized comprising MWCNTs, PMMA and HA, 
which promises to be a superior material for biomedical applications. The selection of 
PMMA was made for two main reasons: (i) PMMA is already used as bone cement, and it is 
highly compatible with HA, and (ii) MWCNTs are highly stable in its original form and 
PMMA can act as a functionalizing and linking material with HA. 
There are two main goals when preparing the MWCNTs/PMMA/HA nanocomposite, 
namely: (i) to obtain homogenous dispersion of the MWCNTs, ensuring uniform properties 
throughout the composite, and (ii) to enhance the interaction between the MWCNTs and 
mixing material to achieve an appropriate level of interfacial stress transfer. The dispersion 
of the MWCNTs is probably the most pressing issue.  The MWCNTs should be uniformly 
dispersed to guarantee that they are individually coated with PMMA-modified HA 
composite, which is imperative in order to have an efficient load transfer to the MWCNTs 
network. This also results in a more uniform stress distribution and minimizes the presence 
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of loci of high stress concentration. To this purpose the percentage of MWCNTs in the 
nanocomposite material should be controlled – a large amount of MWCNTs cause them to 
bundle up in weakly interacting tubes as a result of the van der Waals attraction (Kis et al., 
2004), and, moreover, it will decrease the interfacial interaction between the mixing material 
and the MWCNTs. 
5.1. Freeze-granulation technique to produce the nanocomposite of PMMA and 
HA with dispersed MWCNTs 
The well dispersed MWCNTs mixture in water was obtained for four different weight 
percentages of MWCNTs, namely 0.01%, 0.1%, 0.5% and 1% MWCNTs, respectively. Each 
solution was mixed with a composite of commercially available PMMA (high viscosity bone 
cement purity >99%, Johnson and Johnson Co.) and HA (particle size 2-3 µm with purity 
>98%, Agoramat-Advanced Materials) in 1:2 weight percentage. The homogenous mixture 
of HA powders and PMMA were prepared by ball-milling (Satish Kumar et al., 1996; Tsang 
et al., 1994; Chen et al., 2005; Walker et al., 2007; Poudyal et al., 2004). There is no effect on 
HA powder size distribution during ball milling it restricts agglomeration of HA powder 
during mixing of PMMA with HA.   
The freeze-granulation technique (Power Pro Freeze-granulator L5-2, Sweden)    was 
performed with the objective of drying the nanocomposite of MWCNTs-reinforced 
PMMA/HA powder to preserve the material homogeneity and enhance the dispersion of the 
nanoparticles in the composite matrix. Figure 2 shows the schematic diagram for the step-
by-step procedure, which yields the synthesis of MWCNTs-reinforced PMMA/HA 
nanocomposite using the freeze-granulation technique. Granules with no cavities can be 
performed and no migration of small particles will give a high degree of granule 
homogeneity, while mild drying avoids oxidation of the powder. Also, lower granule 
density and the aid of evenly distributed low concentration MWCNTs will give softer 
granules with a wide granule size distribution. The freeze dried nano-particles were then 
collected and finally dried in vacuum for 3 days. In order to dry any remaining liquid the 
nano-composite was kept for 24 hours in the oven set at 40oC. 
5.2. Surface characterization and mechanical properties 
Field-Emission Scanning Electron Microscopy (Hitachi S-800, and SU-70, 30 keV) was 
performed to study the dispersion and distribution of the MWCNTs in PMMA modified HA 
matrix. The phase composition and purity of the samples were investigated by using the 
Philips Xpert-MPD X-ray powder diffractometer with Co Kα radiation at 45 kV and 40 mA. 
Room temperature micro-Raman studies were also performed to study the integration of 
MWCNTs with the PMMA-HA nanocomposite material. Figures 3-6 show the surface 
morphology of the MWCNTs-reinforced samples for 0.00%, 0.01%, 0.1% and 1.0% of 
MWCNTs, respectively. From the SEM observations for different concentrations of 
MWCNTs reinforced samples, it is clearly observed the concentration of 0.1% of MWCNTs 
yields the best reinforcement for the PMMA/HA nanocomposite (Figures 5 a,b). For 0.1%  
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Figure 2. Schematic diagram for the formation of MWCNTs-reinforced PMMA/HA nanocomposite by 
the freeze-granulation technique 
oncentration of MWCNTs, an intercalation of the PMMA/HA composite inside the 
MWCNTs distribution does occur (Figures 6 a,b), leading to an increase in the MWCNTs 
dispersion. Below this concentration, the mutual interaction between two adjacent 
MWCNTs is practically non-existent, which tends to decreases the homogeneity of the 
nanotubes inside the PMMA/HA matrix. Figure 2 depicts the surface morphology of the 
0.01% MWCNTs -PMMA/HA nanocomposite. At higher nanotube concentrations, because 
less PMMA/HA is available to intercalate into the MWCNTs distribution may lead to weak 
bonding between the PMMA/HA and MWCNTs, making the composite weak in strength. 
The SEM image of 1% MWCNTs -PMMA/HA composite shows agglomeration of MWCNTs 
into bundles. This indicates that the PMMA/HA did not intercalate into the bundles. Only 
the outside nanotubes of a bundle can be bonded to the composite (Figure 5.6). 
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Figure 3. FE-SEM image showing the surface morphology of 0.00% MWCNTs-PMMA/HA 
nanocomposite, prepared by ball milling. The blue and green dotted arrows indicate HA and PMMA 
phases in the PMMA/HA composite.  
 
 
Figure 4. FE-SEM image showing the surface morphology for 0.01% MWCNTs -PMMA/HA 
nanocomposite, prepared by freeze-granulation technique. From this image (indicated by a red dotted 
arrow), it can be observed that some MWCNTs sheathed with the PMMA/HA nanocomposite. 
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Figure 5. (a) FE-SEM image showing the surface morphology of 0.1% MWCNTs-PMMA/HA 
nanocomposite. (b) Shows the highly magnified SEM image of the area denoted by a green dotted 
square in (a) and the red dotted arrows point to isolated MWCNTs, which are completely covered by 
the PMMA/HA matrix. 
 
Figure 6. (a,b) FE-SEM images performed at various locations of the 1% MWCNTs -PMMA/HA 
composite sample shows agglomeration of MWCNTs networks (denoted by the red dotted arrows). 
This indicates that PMMA/HA did not intercalate into the networks; therefore, only the outside 
nanotubes of a network can bind to the composite. 
Figure 7 illustrates the X-ray diffraction (XRD) patterns of PMMA, HA and 0.1% MWCNTs-
PMMA/HA, respectively. It is clearly shown the main constituent phases of the composite 
are crystalline HA (Haque et al., 2007; Bouyer et al., 2000) (JCPDS 09-0432). No MWCNTs 
peaks were found in the XRD pattern of the 0.1% MWCNTs-PMMA/HA composite, most 
likely because for small percentages of MWCNTs detection is not possible within the 
sensitivity limit of XRD. Miller indices of the diffraction peaks are given in parentheses. 
PMMA, which is an amorphous polymer (Meneghetti et al., 2004), shows a broad peak at 2θ 
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value of 13o. The shape of the most intense broad peak reflects the ordered packing of 
polymer chains (Ryu et al., 2004). 
 
Figure 7. XRD results of PMMA, HA and 0.1% MWCNTs-PMMA/HA, respectively, in the composite. 
PMMA presents a broad amorphous peak at 2θ value of 13o. 
 
Figure 8. (a) FE-SEM image of 0.1% MWCNTs-reinforced PMMA/HA sample prepared by freeze-
granulation technique (b) Raman spectra (denoted by the blue line) collected from a 0.1% MWCNTs-
reinforced PMMA/HA sample shown in (a). 
The visible Raman spectra collected from the 0.1% MWCNTs-reinforced PMMA/HA sample 
(Figure 8a) denoted by a blue line in Figure 8b, shows several distinct features. The feature 
near 1773 cm-1 is attributed to C=O. O bonded and indicates that COO- functional groups in 
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functionalized MWCNTs interact with C=O of PMMA (Velasco-Santos et al., 2003; Velasco-
Santos et al. 2002; Hong et al., 2002). Also, it can be observed several other peaks at 602 
(PO43-), 962 (PO43-), 1592 (tangential mode) and 814 (symmetric CC4 stretching), 1452 (CH 
bending), 1123 (C-O stretching), 1724 (-C=O stretching), 2952 (CH stretching) cm-1 which are 
due to the HA, MWCNTs and PMMA, respectively (Paillet et al., 2004; de Mul et al., 1986; 
Suzuki et al., 1991; Kim et al., 2004; Matsushite et al., 2000).  
Nanoindentation tests were performed using a MTS Nano Indenter XP with a Berkovich 
diamond tip. Hardness and elastic modulus of the PMMA/HA nano-composite with 
different percentage of MWCNTs were measured as a function of the indentation depth 
using a continuous stiffness measurement (CSM) method. The typical nanoindentation test 
consists of seven subsequent steps: approaching the nanocomposite surface; determining the 
contact point; loading to peak load; holding the tip for 10 s at the peak load; unloading 90% 
of peak load; holding the tip for 100 s at 10% of the peak load for thermal drift correction; 
and finally, unloading completely. The hardness and elastic modulus were obtained from 
the curves using the Oliver-Pharr method (Suzuki et al. 1991).  
In the present work the nanoidentation technique is employed to study the variation of the 
mechanical properties of MWCNTs-reinforced PMMA/HA composite with different 
concentrations of MWCNTs. Figure 9 displays the typical load-displacement curves at a 
peak indentation load of 10 mN on the MWCNTs-reinforced PMMA/HA composite; it 
clearly demonstrates that no cracks were formed during indentation. A considerable 
amount of creep strain at the peak load was found for all the samples. The holding segment 
at the peak load is necessary for the dissipation of creep displacement; most polymeric 
biomaterials and tissues often exhibit this type of time-dependent or viscoelastic behaviour 
(Li and Bhushan, 2002; Bhushan, 2003). 
 
Figure 9. Typical load-displacement curves of indentations made at a peak indentation load of 10 mN 
on the PMMA/HA nanocomposite and its MWCNTs-reinforced samples. 
 
Biomedical Engineering – Technical Applications in Medicine 126 
To study the effect of dispersion of nanotubes in the PMMA/HA composite, hardness and 
elastic modulus values are needed for both small and large indentation depths. Thirty two 
nanoindentation tests were carried out on each sample, and the experimental errors are 
±0.60 GPa for the elastic modulus and ±0.05 GPa for the hardness. The hardness and elastic 
modulus values as a function of the indentation depth for PMMA/HA and its MWCNTs 
reinforced samples are presented in Figure 10 and the average hardness and elastic modulus 
for these composites are listed in Table I. It can be observed the hardness and elastic 
modulus of these composites increase with increasing MWCNTs content up to 0.1%. Beyond 
this value, as it can be noted from Figure 8a, an increase in MWCNTs content yields a 
considerable decrease of the hardness. 
 
Figure 10. Hardness (a) and elastic modulus values (b) as a function of the indentation depth. 
 
 
0.00% 
MWCNTs-
PMMA/HA 
0.01% 
MWCNTs-
PMMA/HA 
0.1% 
MWCNTs-
PMMA/HA 
0.5% 
MWCNTs-
PMMA/HA 
1% 
MWCNTs-
PMMA/HA 
H (GPa) 0.288 0.510 3.460 1.321 0.624 
E (GPa) 5.949 14.022 69.528 28.08 10.56 
Table 1. Average values of hardness and elastic modulus for different concentrations of MWCNTs in 
the PMMA/HA composite.  
In a previous publication (Shokuhfar et al., 2007), the authors demonstrated that there are several 
key requirements for an optimal fibre-reinforced, polymer-based, composite system, namely: (a) 
The fibres should be long enough so that the stress developed within them is significantly larger 
than the nominal stress on the composite; (b) The cross-sectional area of the fibre should be as 
small as possible - the strength of the fibre is inversely proportional to the square root of its 
maximum flaw size; therefore  for smaller cross-sectional areas the appearance of flaws is 
reduced; (c) The spatial arrangement of the fibres in the matrix has to be of a significant order to 
ensure a unidirectional, maximal reinforcement. Also self-consistent calculations lead to the 
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conclusion that an isotropic arrangement of the fibres will result in the dilution of the 
reinforcement effect within the polymer matrix. Previously, the law of volumetric mixtures was 
used to analyse the mechanical behaviour of a continuous media of PMMA/HA with a blend of 
carbon nanotubes distributed in the matrix. According to the numerical calculations (Shokuhfar 
et al., 2007) carried out the Young Modulus of the composite increases with increasing MWCNTs 
concentration up to a concentration around 10 %. The present experimental results show that 
after a concentration of MWCNTs of 0.1 % a noticeable decrease of the Young Modulus is clearly 
identified (Figure 10b). This discrepancy may be due to the fact the modelling did not take into 
account two physical phenomena, which, in view of the experiments, are important, namely: 1) 
the interaction between nanotubes and 2) the character of the interface between the MWCNTs 
and the matrix. Increasing the MWCNT’s concentration up to a certain level promotes a mutual 
interaction between a crossed pair and a coarse mesh of nanotubes (Figure 11). 
 
Figure 11. FE-SEM image showing mutual interactions between crossed pair of nanotubes. 
Consequently, the set of nanotubes can act as a deformation lock, either in extensional or 
shear mode, giving rise to improved mechanical properties. An identical behaviour was 
noticed by analysing the effect of the MWCNTs concentration on a PMMA matrix (Akiskalos, 
2004). It should be mentioned the SEM images clearly show that after a concentration of 0.1% 
for the  MWCNTs, a drop of homogeneity in the nanotubes-matrix contact occurs, giving rise 
to the formation of voids and internal cavities with the eventual reduction in the mechanical 
performance of the composite. In fact, most likely, these defects act as nucleation for internal 
crack tips and mutual link-up modes, with a fast degradation of the structure integrity and 
eventual breakdown. Fatigue tests were performed in artificial bones to confirm this analysis 
(Figure 12). In the tests, after one million of cycles the nanocomposite with 0.1% of MWCNTs-
PMMA/HA does not present any signal of crack propagation and delamination (Figures 12 
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a,b). But when we performed the same type of fatigue tests for only PMMA nanocomposite 
we can clearly observed the delamination and cracks in Figures 12c and d, respectively. 
 
Figure 12. (a,b) Optical microscopic observation of the 0.1% MWCNTs-PMMA/HA nanocomposite at 
the interface with titanium prosthesis after a fatigue test for one million of cycles. (c,d) Optical 
microscopic image shows delamination and cracks after same type of fatigue test for only PMMA 
nanocomposite.   
6. In Vivo studies of carbon nanotube-based nanocomposites 
6.1. In Vivo methods 
Animal Model: Following the experimental protocol approved by the National Ethics 
Committee for Laboratory Animals (Portugal) (Dias et al., 2008), two healthy, adult male 
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sheep with average weight of 45 kg, were used for the in-vivo implantation. The sheep were 
permanently housed indoors in group housing and were kept under a constant photoperiod 
cycle (light: from 07:00 to 19:00 hours; dark: from 07:00 to 19:00 hours), temperature (20 ±  
2 oC) and humidity (50 ± 10%). Food was withdrawn 36 hours, and water 6 hours prior to 
anaesthesia. 
Anesthetic and Surgical Method: Surgery was performed under general anaesthesia, which 
was induced with pentobarbital through intravenous injection; the animals had been 
previously premedicated with xilazine and buprenorphine. The anaesthesia was 
maintained through using isoflurane administered with an endotracheal tube and 
spontaneous ventilation. An electrocardiogram (ECG) monitor and a pulsioximeter were 
used to monitor the condition of the animals.  The antibiotherapy was initiated during 
surgery with amoxicillin (Clamoxyl) and these therapies were maintained for one week. 
The site of the surgery was prepped with a solution of Betadine (povidone-iodine) and 
alcohol (Dura-Prep; 3M Health Care, St. Paul, MN) after the animals were locally shaved. 
For the implantation of the bioactive bone cement in the tibia, the animals were placed in 
a dorsal recumbency position and a longitudinal incision was made on the frontal surface 
of the left and right tibia. After exposure of the tibial bone, the periosteum was reflected 
and a 2.5 mm diameter pilot hole was made with a surgical drill and then enlarged with 
low speed drilling to a 3.0 mm diameter. During the process, the bone was continuously 
perfused with a sterile saline solution. Three holes were drilled on each tibia as shown in 
Fig. 13a and then the holes were filled with the bioactive bone cement paste (Fig. 13b). The 
surgery field was covered with subcutaneous tissue and the skin was closed using 
absorbable Surgicryl ® 2–0 sutures.  
An in vivo paste was prepared by thoroughly mixing a monomer solution of bioactive 
bone cement (Johnson and Johnson Co.) with our dry powder containing the COOH-
MWCNTs-reinforced PMMA/HA nanocomposite. These components were mixed together 
just before the in vivo procedure; the resultant mixture was used as a viscous paste. This 
biocomposite was implanted into a sheep model system, in a similar manner to previous 
protocols (Dias et al., 2008; Henriksen et al., 2009). For the implantation, three holes were 
drilled in each tibia (Figure 13a) and then the holes were filled with the bioactive bone 
cement paste (Figure 13b). The field of the surgical procedure was covered with 
subcutaneous tissue, and the skin was closed using absorbable sutures. Post-operative X-
ray tests were conducted to ensure that proper filling of the holes in the bone had 
occurred (Fig. 14i). Twelve weeks after implantation, the animals were sacrificed 
following the experimental protocol approved by the National Ethics Committee for 
Laboratory Animals (Portugal). The implanted material and the surrounding tissue were 
removed. 
Radiological and Histological Studies: Post-operative X-ray tests were performed with a 
Mammodiagnost UC system (Philips) with 28 kV, 25 mA, using coarse focus and Kodak 
Min-R Screen film. Twelve weeks after implantation, the animals were sacrificed with an 
intravenous dose of sodium pentobarbital (Eutasil®). The implanted materials and the 
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surrounding tissue was removed  The bone specimens for the histological evaluation were 
fixed in 4% buffered formaldehyde, dehydrated in graded alcohols and embedded in 
methyl methacrylate (Merck Supplier Part: 8.00590.1000). After polymerization, non-
decalcified 30 µm sections were obtained in the transversal direction using a saw 
microtome (Leica 1600) and then ground with silicon carbide powder. Thin sections were 
prepared of each specimen for evaluation by light microscopy (Eclipse 600, Nikon Japan). 
The bone sections were stained with toluidine blue (Brancroft and Stevens, 1996; Schipper 
et al., 2008).  
 
 
 
Figure 13. (a) Optical image of three holes drilled in tibial bone of a sheep before implantation (b) 
Digital image of filling the bone during the surgical procedure with the bioactive bone cement paste in 
three holes of a sheep tibia. 
To examine the in vivo response with the nanocomposites, x-ray tests were performed. After 
twelve weeks the inflammatory reactions in the surrounding tissues were examined. X-rays 
of the left tibia were captured immediately after surgery (Fig. 14i) and then after 12 weeks 
(Fig. 14ii).  The drilled cavities, as indicated by an asterisk in Figures 14(i) and (ii), had been 
invaded by the marrow region. Also, there were no signs of periosteal or bone negative 
reactions twelve weeks after implantation. Figures 14(iii-vi) provided a histological 
evaluation of the stained specimens obtained twelve weeks after implantation. The 
periosteum covering the outer surface of the implant and the cortical bone at the interface 
did not show any adverse reaction to the implants (Fig. 14iii,iv). Furthermore, the contact 
between the cement and the bone showed no fibrous tissues or inflammatory cells as 
observed in Figure 14(iii). Osteocytes (denoted by red dotted circle in Fig. 14iii) were clearly 
observed. At higher magnifications, a favourable interface between bone and the cement 
was observed (Fig. 14iv). However, in the areas where there was no direct contact between  
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Figure 14. In-vivo response with the nanocomposite bone cement in sheep. (i) X-rays (left tibia) 
immediately after surgery and (ii) after 12 weeks. Invasion of the marrow region (indicated by the 
asterisk) and restoration of the cavities is observed. There are no inflammatory reactions in the 
surrounding tissues after 12 weeks.  (iii) An image of Giemsa surface staining of the specimens at 12 
weeks after implantation shows excellent contact between the nanocomposite PMMA-HA-CNT 
bioactive-bone cement (C) and the bone tissue (B) with no fibrous tissues and no inflammatory cell 
infiltration. Oteocytes, which are indicated by the red dotted circle regions, are observed (iv) An image of 
Giemsa surface staining focusing on the interface between the nanocomposite bioactive-bone cement and 
the tissue (C) and the bone tissue (B), which is very favourable. (v) An image of Giemsa surface staining 
focusing revealing multinuclear osteoclast-like cells covering the surface of the bone cement, as indicated 
by the green dotted circles; there was no direct contact between bioactive-bone cement (C) and bone 
tissue (B) generally observed. (vi) An image of Giemsa surface staining focusing showing that the new 
bone (B) clearly enters into the pores of the bone cement (C), as indicated by the green dotted arrow. 
the bone and the implant, osteoclast-like-cell (Yavropoulou and Yovos, 2008) appeared on the 
cement surface (indicated by the green dotted circle in Fig. 14v). Furthermore, in our 
specimens (Fig. 14vi), new bone (B) clearly penetrated the pores of the bone cement (C), as 
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indicated by the green dotted arrow. The biocompatibility and osteoconductivity are critical 
factors as foreign material reside in-vivo. A post-mortem examination of the tibias revealed that 
the implants were completely covered by the periosteum. This finding was determined by 
fixing the regional lymph nodes with 4% formaldehyde, embedding them in paraphin, and 
then cutting them into 30 µm sections with a microtome (Leica, Jung RM 2045). The specimens 
were stained with hematoxylin/eosin to examine the biocompatibility and osteoconductivity 
responses. The histological response of the regional lymph nodes revealed no significant 
morphologic changes in the regional lymph nodes between the control and test groups. The 
histological evaluations demonstrate that the CNT-reinforced composite with the bioactive-
bone cement responded favourably as a tibial bone implant based on its osteoconductivity and 
biocompatibility results. This biocompatibility has been demonstrated for an extended time 
period of 12 week post-operation for our 0.1% MWCNTs-PMMA/HAp nanocomposites. 
7. Conclusions 
Herein, we demonstrate a freeze-granulation technique to synthesis a novel nanocomposite of 
carbon nanotube reinforced PMMA/HA for next generation biomedical applications. By 
using this method it is possible to increase material homogeneity and also optimize the % of 
MWCNTs in the PMMA/HA matrix. We shows that the concentration of 0.1% of MWCNTs 
performs the best reinforcement for the PMMA/HA nanocomposites. The hardness and 
elastic modulus of MWCNTs-reinforced PMMA/HA nanocomposites increase with the 
increasing concentration of nanotubes up to around 0.1% in weight. Beyond this limit, 
further addition of MWCNTs in PMMA/HA matrix yields a considerable decrease of these 
mechanical properties. This can be explained in terms of the nanotube-matrix contact 
homogeneity – a further increase of the nanotubes may lead to the formation of voids and 
internal cavities, which can negatively impact the mechanical performance of the composite. 
In addition to this, we have found that the use of COOH-functionalized MWCNTs reinforced 
with PMMA/HA will provide tremendous advancements in the field of regenerative medicine. 
Of singular importance is the mechano-physical advantage this nanocomposite, which 
provides for bearing mechanical loads and promoting osteointegration with surrounding bone 
tissues. These are features not observed with previous materials. Our in vivo animal studies 
shows, new bone extended into the bioactive bone cement. These results confirm that this 
novel bionanocomposite will be an excellent candidate for bone integration due to its 
osteoconductivity and biocompatibility. We believe that these results will have applications in 
a diversity of areas including nanotechnology, biomaterials, and regenerative medicine. 
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